Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes.
Saved in:
| Title: | Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. |
|---|---|
| Authors: | Venkadakrishnan VB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Presser AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Singh R; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Booker MA; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA., Traphagen NA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Weng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Boston College, Chestnut Hill, MA, USA., Voss NCE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Belmont Hill School, Belmont, MA, USA., Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Mizuno K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Puca L; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Idahor O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard University, Cambridge, MA, USA., Ku SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Bakht MK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Borah AA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Urology, University of California at San Francisco, San Francisco, CA, USA.; Arc Institute, Palo Alto, CA, USA., Herbert ZT; Molecular Biology Core Facilities, Dana-Farber Cancer Institute, Boston, MA, USA., Tolstorukov MY; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA., Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rickman DS; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. himisha_beltran@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. himisha_beltran@dfci.harvard.edu.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA. himisha_beltran@dfci.harvard.edu. |
| Source: | Nature communications [Nat Commun] 2024 Aug 08; Vol. 15 (1), pp. 6779. Date of Electronic Publication: 2024 Aug 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39117665 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Venkadakrishnan+VB%22">Venkadakrishnan VB</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Presser+AG%22">Presser AG</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Singh+R%22">Singh R</searchLink>; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Booker+MA%22">Booker MA</searchLink>; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Traphagen+NA%22">Traphagen NA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Weng+K%22">Weng K</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Boston College, Chestnut Hill, MA, USA.<br /><searchLink fieldCode="AU" term="%22Voss+NCE%22">Voss NCE</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Belmont Hill School, Belmont, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mahadevan+NR%22">Mahadevan NR</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mizuno+K%22">Mizuno K</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Puca+L%22">Puca L</searchLink>; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Idahor+O%22">Idahor O</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard University, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ku+SY%22">Ku SY</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bakht+MK%22">Bakht MK</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Borah+AA%22">Borah AA</searchLink>; The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Urology, University of California at San Francisco, San Francisco, CA, USA.; Arc Institute, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Herbert+ZT%22">Herbert ZT</searchLink>; Molecular Biology Core Facilities, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tolstorukov+MY%22">Tolstorukov MY</searchLink>; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Barbie+DA%22">Barbie DA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rickman+DS%22">Rickman DS</searchLink>; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Brown+M%22">Brown M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Beltran+H%22">Beltran H</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. himisha&#95;beltran@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. himisha&#95;beltran@dfci.harvard.edu.; The Broad Institute of MIT and Harvard, Cambridge, MA, USA. himisha&#95;beltran@dfci.harvard.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Aug 08; Vol. 15 (1), pp. 6779. <i>Date of Electronic Publication: </i>2024 Aug 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39117665 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-024-51156-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 6779 Titles: – TitleFull: Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Venkadakrishnan VB – PersonEntity: Name: NameFull: Presser AG – PersonEntity: Name: NameFull: Singh R – PersonEntity: Name: NameFull: Booker MA – PersonEntity: Name: NameFull: Traphagen NA – PersonEntity: Name: NameFull: Weng K – PersonEntity: Name: NameFull: Voss NCE – PersonEntity: Name: NameFull: Mahadevan NR – PersonEntity: Name: NameFull: Mizuno K – PersonEntity: Name: NameFull: Puca L – PersonEntity: Name: NameFull: Idahor O – PersonEntity: Name: NameFull: Ku SY – PersonEntity: Name: NameFull: Bakht MK – PersonEntity: Name: NameFull: Borah AA – PersonEntity: Name: NameFull: Herbert ZT – PersonEntity: Name: NameFull: Tolstorukov MY – PersonEntity: Name: NameFull: Barbie DA – PersonEntity: Name: NameFull: Rickman DS – PersonEntity: Name: NameFull: Brown M – PersonEntity: Name: NameFull: Beltran H IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 08 Text: 2024 Aug 08 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |